APA citiranje

Dymond, A. W., Martin, P., So, K., Huang, Y., Severin, P., Holmes, V., . . . Marbury, T. (2016). Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End‐Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy Subjects. J Clin Pharmacol.

Citação norma Chicago

Dymond, Angela W., Paul Martin, Karen So, Yifan Huang, Paul Severin, Victoria Holmes, Gabriella Mariani, and Thomas Marbury. "Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End‐Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy Subjects." J Clin Pharmacol 2016.

MLA citiranje

Dymond, Angela W., et al. "Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End‐Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy Subjects." J Clin Pharmacol 2016.